Literature DB >> 33967542

Chorea-acanthocytosis: A Case Report with Review of Oral Manifestations.

Aadithya B Urs1, Jeyaseelan Augustine1, Azhar Ahmed Khan1.   

Abstract

Chorea-acanthocytosis (ChAc) is an autosomal recessive, progressive neurological disorder due to mutation in VPS13A gene causing defects in sorting of protein making the cell membrane unstable, leading to star-shaped erythrocytes. This neurological disorder includes features such as elevated creatinine kinase, atrophy of basal ganglia, and oral manifestations such as frequent cheek and tongue biting. It is a rare neurological condition with an estimate of <1000 cases worldwide. A case of 47-year-old male patient with a history of seizures and neurological problems presenting with oral ulceration has been discussed. The diagnosis of ChAc was confirmed by molecular investigations showing VPS13A gene mutation. The physical appearance includes chorea and dystonia with impaired gait. We attempt to highlight the oral features of ChAc. The oral manifestations include frequent tongue and cheek biting occurring due to dystonia affecting the muscles of head and neck region. Copyright:
© 2021 Contemporary Clinical Dentistry.

Entities:  

Keywords:  Chorea-acanthocytosis; orofacial dyskinesia; oromandibular dystonia

Year:  2021        PMID: 33967542      PMCID: PMC8092098          DOI: 10.4103/ccd.ccd_207_20

Source DB:  PubMed          Journal:  Contemp Clin Dent        ISSN: 0976-2361


  10 in total

1.  Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.

Authors:  G-Y R Hsiung; S K Das; R Ranawaya; A-L Lafontaine; O Suchowersky
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Neuroacanthocytosis.

Authors:  David Robinson; Michael Smith; R Reddy
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

3.  Clinical and molecular genetic assessment of a chorea-acanthocytosis pedigree.

Authors:  Mio Ichiba; Masayuki Nakamura; Akira Kusumoto; Emiko Mizuno; Yutaka Kurano; Mieko Matsuda; Maiko Kato; Asumi Agemura; Yuko Tomemori; Shinji Muroya; Yoshiaki Nakabeppu; Akira Sano
Journal:  J Neurol Sci       Date:  2007-08-01       Impact factor: 3.181

4.  Choreoacanthocytosis with marked dysphagia and laryngeal dystonia.

Authors:  M Behari; P Saha; K Prasad; G K Ahuja
Journal:  J Assoc Physicians India       Date:  1991-12

5.  Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis.

Authors:  Benedikt Bader; Ruth H Walker; Mathias Vogel; Mario Prosiegel; Jacqueline McIntosh; Adrian Danek
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

Review 6.  Neuroacanthocytosis.

Authors:  Adrian Danek; Ruth H Walker
Journal:  Curr Opin Neurol       Date:  2005-08       Impact factor: 5.710

7.  Acanthocytosis and neurological disorder without betalipoproteinemia.

Authors:  E M Critchley; D B Clark; A Wikler
Journal:  Arch Neurol       Date:  1968-02

Review 8.  Clinical features and molecular bases of neuroacanthocytosis.

Authors:  Luca Rampoldi; Adrian Danek; Anthony P Monaco
Journal:  J Mol Med (Berl)       Date:  2002-06-18       Impact factor: 4.599

9.  Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases.

Authors:  R J Hardie; H W Pullon; A E Harding; J S Owen; M Pires; G L Daniels; Y Imai; V P Misra; R H King; J M Jacobs
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

Review 10.  Neuroacanthocytosis syndromes.

Authors:  Hans H Jung; Adrian Danek; Ruth H Walker
Journal:  Orphanet J Rare Dis       Date:  2011-10-25       Impact factor: 4.123

  10 in total
  2 in total

Review 1.  Movement Disorders and the Gut: A Review.

Authors:  Lauren S Talman; Ronald F Pfeiffer
Journal:  Mov Disord Clin Pract       Date:  2022-02-05

2.  Biological Function and Clinical Value of VPS13A in Pan-Cancer Based on Bioinformatics Analysis.

Authors:  Xue Qin Zhang; Li Li
Journal:  Int J Gen Med       Date:  2021-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.